Statins for people at low risk of cardiovascular disease

The Lancet

Volumn 380, Issue 9856, 2012, Pages 1816-

  Ray, Kausik K ^a   Redberg, Rita F ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; HUMAN; LETTER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; BLOOD; NOTE; VASCULAR DISEASE;

CHOLESTEROL, LDL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; VASCULAR DISEASES;

EID: 84869462142     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)62024-8     Document Type: Letter

References (2)

1. Cholesterol Treatment Trialists' (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012; 380: 581-90.
2. Pencina M, D'Agostino RB, Larson MG, et al. Predicting the 30 year risk of cardiovascular disease. Circulation 2009; 119: 3078-84.